急性ST段抬高型心肌梗死临床路径实践分析

Implementation of Clinical Pathway for Acute ST Segment Elevation Myocardial Infarction

目的探讨临床路径在急性ST段抬高型心肌梗死中的应用效果。方法采用非同期队列研究方法,将临床路径实施后设为路径组(71例),临床路径实施前设为对照组(67例),观察两组住院时间、住院总费用和住院各分项费用变化情况。结果路径组住院时间、住院总费用低于对照组,差异有统计学意义(P<0.05);各分项费用中,路径组药费、床位费低于对照组,差异有统计学意义(P<0.05);其它分项费用差异无统计学意义(P>0.05)。结论急性ST段抬高型心肌梗死临床路径的实施可降低住院时间及部分住院费用,对规范医疗行为有积极意义。

Objective To evaluate the effect of clinical pathway for acute ST segment elevation myocardial infarction. Meth- od Total 71 cases of acute ST segment elevation myocardial infarction were employed for clinical pathway, while 67 cases before implementation of clinical pathway were taken as control. The outcome measures were length of stay, total medical cost and item- ized cost. Result The length of stay and total cost in clinical pathway group was lower than that in the control group （ P 〈 0.05 ）. For the itemized cost, the medicine cost and bed fee in clinical pathway group was lower comparing to control group （ P 〈 0.05 ） , while other itemized cost showed no significant difference （ P 〉 0.05 ）. Conclusion The length of stay and parts of the hospitali- zation expenses could be lowered down after implementation of clinical pathway for acute ST segment elevation myocardial infarc- tion, which has positive meaning for standardization of medical care conduct.